Abstract
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.thromres.2021.11.008
Copy DOIJournal: Thrombosis Research | Publication Date: Nov 16, 2021 |
Citations: 2 | License type: NO-CC CODE |
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.